Flu season visitor restriction – age 16 or older (Restricción de visitantes durante la Temporada de Influenza (Flu) – Mayores de 16 años.)

Flu Season Visitor Restriction

Visitors temporarily restricted to age 16 or older

As a safety first organization, ChristianaCare is implementing a temporary visitation age restriction starting Tuesday, Jan. 21. This temporary restriction protects patients, their loved ones and health care workers during this time of extremely high number of influenza cases and other respiratory illnesses circulating in our community.

The new restrictions limit visitors to patients in Christiana and Wilmington hospitals to persons age 16 or older. Children and teens younger than 16 years are most likely to get the flu and remain contagious longer than adults. This restriction does not apply to outpatient and ambulatory services.

Thank you for your understanding and cooperation.

For more information about the Flu visit our Health Library.

Restricción de visitantes durante la Temporada de Influenza (Flu)

Temporalmente solo se permiten los visitantes mayores de 16 años.

Como una organización que promueve la seguridad ante todo, ChristianaCare está implementando una restricción temporal en la edad de visitantes a partir del viernes 21 de enero. Esta restricción temporal protege a los pacientes, a sus seres queridos y al personal de cuidados de salud durante esta época con un número extremadamente alto de casos de influenza y de otras enfermedades respiratorias que circulan en nuestra comunidad.

Las nuevas restricciones, en los hospitales Christiana y Wilmington, sólo permiten visitas a pacientes de personas mayores de 16 años. Los niños y adolescentes menores de 16 años son más propensos a contraer el flu y son contagiosos por más tiempo que los adultos. Esta restricción no aplica a las áreas de servicios ambulatorios.

Gracias por su comprensión y cooperación.

Para más información sobre la gripe, visite nuestra Biblioteca de Salud.

Helen F. Graham Cancer Center
& Research Institute

Thoracic Surgery

ChristianaCare’s Division of Thoracic Surgery is a high-volume center that provides world-class treatment for a wide range of malignant and non-malignant conditions affecting the:

    • Lung.
    • Esophagus.
    • Thymus.
    • Mediastinum.
    • Chest wall.
    • Diaphragm.

Our dedicated team of physicians is committed to achieving the best possible outcome for each of our patients. Our goal is to not only provide the finest care for our patients today, but to continually advance the quality and effectiveness of the surgical treatment options of tomorrow. Our surgeons are active investigators involved in collaborative research and medical education. They are ongoing participants in an array of national and international studies and clinical trials. Their work has been published in a variety of medical texts and peer-reviewed journals. Their achievements have been recognized with academic appointments to the University of Delaware and some of the area’s most respected medical colleges.

What truly sets our surgeons apart, however, is their expertise in thoracic surgery and their focus on compassionate, outstanding patient care.

Specialists in malignant and non-malignant disease

Our surgeons employ the most advanced technology and techniques in the management of malignant and non-malignant disease, including:

    • Aerodigestive tract stenting (lung and esophagus).
    • Minimally-invasive cancer staging and treatment.
    • Radiofrequency ablation of lung tumors (RALT).
    • Surgical resection for lung, esophageal, thymic and other chest malignancies.
    • Surgical management of lung metastases.
    • Transthoracic and Transhiatal esophagectomy.
    • Video-assisted thorascopic (VATS) lobectomies.
    • Hiatal hernia repair and anti-reflux surgery.
    • Bullectomy for emphysema.
    • Surgical treatment of esophageal dysmotility conditions.
    • VATS resection of mediastinal cysts and posterior mediastinal neuogenic tumors.
    • VATS sympathectomy.
    • VATS vagotomy.

As members of the Helen F. Graham Cancer Center’s Thoracic and Esophageal Cancer Multidisciplinary Center, our thoracic surgeons participate in the multi-modality treatment for patients with lung cancer, esophageal cancer, mesothelioma and other malignancies of the chest.

Leading the way to treatment advances

Our surgical team is actively engaged in collaborative research and clinical trials in an effort to discover new ways to diagnose and treat lung cancer. These include:

Division of Thoracic Surgery
Helen F. Graham Cancer Center & Research Institute
4701 Ogletown-Stanton Road, Newark, DE 19713 directions